Cancer of Lung

22 registered clinical trials studyying Cancer of Lung — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Impact of Psychological Stress on Treatment Response and Prognosis in Lung Cancer Patients NCT06964503	The First Affiliated Hospital of Guangzhou Medical University	—
Recruiting	Precision Lung Cancer Survivorship Care Intervention NCT05857995	Jerod L Stapleton, PhD	N/A
Unknown	Effect of 3D-printed Reconstruction System in Size of Left DLT NCT06258954	Sichuan Cancer Hospital and Research Institute	N/A
Enrolling By Invitation	Real-time Motion Management During Prostate and Lung Radiotherapy NCT05844761	Region Skane	N/A
Completed	Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® NCT05011890	UNC Lineberger Comprehensive Cancer Center	N/A
Completed	4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Te NCT04717804	The University of Texas Health Science Center at San Antonio	N/A
Active Not Recruiting	Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation NCT04699188	Novartis Pharmaceuticals	Phase 1 / Phase 2
Active Not Recruiting	High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM) NCT04263467	Herlev Hospital	N/A
Active Not Recruiting	Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma NCT04300244	Åslaug Helland	Phase 2
Unknown	The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor NCT03896958	SpeciCare	—
Terminated	NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung NCT03603652	Ethicon, Inc.	N/A
Completed	Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung NCT02410603	Mayo Clinic	—
Unknown	Changing Over Time of Ascorbic Acid After Chemotherapy NCT02931942	Maastricht University Medical Center	—
Completed	Real-time Activity Monitoring to Prevent Admissions During RadioTherapy NCT03102229	Montefiore Medical Center	N/A
Terminated	MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) NCT02673021	Mayo Clinic	N/A
Terminated	Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma NCT02549638	Mayo Clinic	—
Completed	Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung NCT02853188	Hopital Foch	N/A
Completed	An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors NCT02616211	Mayo Clinic	—
Completed	A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System NCT02370303	Mayo Clinic	—
Completed	Study of Arsenic Trioxide in Small Cell Lung Cancer NCT01470248	Emory University	Phase 2
Completed	A Phase I Study of iPS Cell Generation From Patients With COPD NCT01860898	Mayo Clinic	N/A
Completed	LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chem NCT00328588	Astellas Pharma Inc	Phase 2